Relay Therapeutics Inc (RLAY) shares plummeted over 17% on Wednesday after the company announced a $200 million stock offering. The offering, led by Goldman Sachs, TD Cowen, Stifel, and BofA Securities, is expected to close around September 12th. Investors are considering the impact of this offering on the stock’s future performance, with the RSI indicating overbought conditions.